Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Has results × Vigabatrin × Clear all

Phase

Phase 4 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Tuberous Sclerosis 1 Seizures 1

Interventions

Saline Solution 10 Docetaxel 10 Bevacizumab 9 nilotinib 8 enzalutamide 8 Paclitaxel 8 Letrozole 8 Fentanyl 8 Everolimus 8 Cyclophosphamide 8 Carboplatin 8 Bupivacaine 8 Lidocaine 7 Sodium Chloride 6 Oxycodone 6 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 6 Erlotinib Hydrochloride 6 Dexamethasone 6 Capecitabine 6 Trastuzumab 5 Tobacco Use Cessation Devices 5 Surveys and Questionnaires 5 Nivolumab 5 Hydromorphone 5 Adalimumab 5 fludarabine 4 Zoledronic Acid 4 Tranexamic Acid 4 Tacrolimus 4 Rocuronium 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01266291 2017-07-12

STARS

University of Pennsylvania

Phase 4 Terminated

1 enrolled 8 charts

Seizures, Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡